Ebola Drug Used on Two Americans Works in Monkey Study
This article is for subscribers only.
Monkeys infected with Ebola survived after being treated with an experimental drug from Mapp Biopharmaceutical Inc., in a study that suggests the drug may be effective even after severe symptoms are present.
Monkeys were given three doses of the antibody-based treatment ZMapp starting three to five days after being infected with a lethal dose of Ebola. All 18 monkeys treated with ZMapp survived, while three that weren’t given the medicine died, according to the results published in the journal Nature.